PSTV
USDPLUS THERAPEUTICS Inc. Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$0.500
고가
$0.519
저가
$0.491
거래량
5.03M
기업 기본 정보
시가총액
70.0M
산업
생명공학
국가
United States
거래 통계
평균 거래량
20.11M
거래소
NCM
통화
USD
52주 범위
관련 뉴스
HC Wainwright & Co. Maintains Buy on Plus Therapeutics, Lowers Price Target to $2
HC Wainwright & Co. analyst Sean Lee maintains Plus Therapeutics with a Buy and lowers the price target from $3 to $2.
D. Boral Capital Maintains Buy on Plus Therapeutics, Maintains $5 Price Target
D. Boral Capital analyst Jason Kolbert maintains Plus Therapeutics with a Buy and maintains $5 price target.
Plus Therapeutics Reports Third Quarter Financial Results and Recent Business Highlights
US market introduction of the CNSide® CSF diagnostics platform, with first national coverage agreement with UnitedHealthcare Presented positive RESPECT-LM Ph1 clinical trial results HOUSTON, Oct. 30, 2025 (GLOBE
Plus Therapeutics Updates on CNSide® Diagnostic Platform Launch
Expands commercial readiness and diagnostic, manufacturing footprint Appoints new leadership in commercial strategy and technical operations HOUSTON, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc.
관련 주식
최신 정보 받기
가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기